ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Nasal potential difference measurements in cystic fibrosis

Nasal potential difference measurements in cystic fibrosis
Examples of nasal PD tracings in a normal patient (Panel A) and in a patient with cystic fibrosis (Panel B). The x-axis is time (minutes) as described, and the y-axis is nasal PD (mV; upward is polarizing). The normal phenotype includes a lower (less polarized) baseline PD in solution #1, a small depolarizing change in PD after amiloride perfusion (solution #2), and a repolarizing PD after perfusion with low-chloride (0 [CI-]) and low-chloride + isoproterenol (solutions #3 and #4: continued presence of amiloride). The cystic fibrosis phenotype includes a higher (more polarized) baseline PD, a large depolarizing change in PD after amiloride perfusion, and absent repolarization after perfusion with 0 [CI-] and 0 [CI-] + isoproterenol. ATP-stimulated PD (solution #5, reflecting stimulation of calcium-activated chloride conductance) is retained in normal subjects and in subjects with cystic fibrosis.
PD: potential difference.
Reproduced with permission from: Clancy JP, Rowe SM, Bebok Z, et al. No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations. Am J Respir Cell Mol Biol 2007; 37:59. Official Journal of the American Thoracic Society. Copyright ©2007 American Thoracic Society.
Graphic 67877 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟